★★

Moadata

Moadata Q1 2026: Loss Widens, Financial Health Deteriorates


  • Consolidated Q1 2026 revenue decreased 27.5% YoY to 4.39 billion won from 6.05 billion won.
  • Net loss widened to 3.46 billion won (vs 1.77 billion won in Q1 2025), EPS -100 won.
  • Debt ratio surged to 372.3% from 303.8% at year-end, worsening financial health.
  • Cash and cash equivalents fell to 1.87 billion won from 3.68 billion won, increasing liquidity risk.
  • High customer concentration: 57.1% of sales from a single client (H Co.).
  • Potential dilution from convertible bonds and warrants (approx. 21.6 million shares exercisable).
  • No share buyback, cancellation, or dividend plan.
  • Credit ratings remain speculative: BB- (public) / B+ (private).
  • R&D spending at 43.5% of revenue continues, but near-term profitability improvement unlikely.
  • Allowance for bad debts ratio increased to 17.1% from 13.9%, indicating higher collection risk.
ADVERTISEMENT (250px+)

KOSDAQ Filing Information


  • Filing: Quarterly Report (2026.03)
  • Company: Moadata (288980)
  • Submission: Moadata Co., Ltd.
  • Receipt: 05-15-2026